Investing Profile

George C. Petrocheilos

InvestorVCFounder
Co-Founder & Managing Partner at Catalio Capital Management
cataliocapital.com/team/georg...New York, New York
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
Your Intro Paths to George C. Petrocheilos

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find George C. Petrocheilos on

cb
Current Investing Position
Catalio Capital Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
9

George C. Petrocheilos is on these Sector & Stage Rankings

Cybersecurity (Series B)Robotics (Series B)Drug Delivery (Series B)Drug Delivery (Series A)Drug Delivery (Seed)Diagnostics (Series B)Drug Delivery (Series B)Drug Delivery (Seed)Diagnostics (Series A)Drug Delivery (Series B)Drug Delivery (Series A)Diagnostics (Seed)Diagnostics (Series B)Cybersecurity (Series A)Cybersecurity (Seed)Medical Devices (Series B)Drug Delivery (Series A)Medical Devices (Series A)BioTech (Series B)Diagnostics (Series A)Diagnostics (Seed)Medical Devices (Seed)Robotics (Series A)Drug Delivery (Seed)Robotics (Seed)Diagnostics (Series B)Medical Devices (Series B)BioTech (Series A)BioTech (Seed)Medical Devices (Series A)Diagnostics (Series A)Cybersecurity (Seed)Medical Devices (Seed)Diagnostics (Seed)Cybersecurity (Series A)Cybersecurity (Series B)Robotics (Series B)BioTech (Series B)Robotics (Series A)Medical Devices (Series B)Robotics (Seed)BioTech (Series A)Robotics (Series B)Cybersecurity (Series B)Medical Devices (Series A)BioTech (Seed)Medical Devices (Seed)Cybersecurity (Series A)Cybersecurity (Seed)Robotics (Series A)Washington, D.C.BioTech (Series B)Robotics (Seed)BioTech (Series A)BioTech (Seed)New York City

George C. Petrocheilos's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Clasp Therapeutics
Series AMar 2024$150M
$150M
Co-investors: Andrea van Elsas (Third Rock Ventures), Jack Nielsen (Vivo Capital), R. Jacob Vogelstein (Catalio Capital)
Haystack Oncology
Series ANov 2022$56M
$56M
Co-investors: R. Jacob Vogelstein (Catalio Capital)
Anagenex
Series AJun 2022$30M
$30M
Co-investors: Zavain Dar (Dimension Capital), Mei Z.
Octant Bio
Series BApr 2022$80M
$120M
Co-investors: Jorge Conde (Andreessen Horowitz), Katie Haun (Haun Ventures), Ling Wong (Highbury Group), Sujay Jaswa (WndrCo LLC), Lars Fjeldsoe-Nielsen (2xN), Clint Korver (Ulu Ventures), Miriam Rivera (Ulu Ventures), Stephen Hays (What If Ventures)
Pheast Therapeutics
Series AApr 2022$76M
$76M
Co-investors: R. Jacob Vogelstein (Catalio Capital), Steven Gillis (ARCH Venture Partners)
DNA Script
Series CJan 2022$200M
Series COct 2021$170M
$470M
Co-investors: Nick Naclerio (Illumina Ventures), Joško Bobanović (Soffinova Partners), Philippe Peltier (Kurma Partners), Joachim Rothe (EQT Life Sciences)
Sensei Biotherapeutics
Series BJan 2021$30M
$59M
Co-investors: Christian Angermayer (Presight Capital)
Spiral Therapeutics
Series ADec 2018$6M
$6M
Co-investors: Sara Secall (Inveready Technology Investment Group)